Investment platform
Русский
Беларускі
Español
Biogen
Sell176.07
Spread1.28
Buy177.35

Trade Biogen Inc. - BIIB stock price

Sell176.07
Spread1.28
Buy177.35
1m
5m
15m
30m
1H
4H
1D
1W
History
Open on platform
Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis (MS); FUMADERM for the treatment of plaque psoriasis; and SPINRAZA to treat spinal muscular atrophy. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; FLIXABI, an infliximab biosimilar referencing REMICADE; RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), and other conditions; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for the treatment of primary progressive MS and relapsing MS, and other anti-CD20 therapies. The company's Phase II clinical trial products comprise Opicinumab for MS; BAN2401 for Alzheimer's disease; BIIB092 for PSP; Natalizumab for Acute Ischemic Stroke and Epilepsy; and BG00011 for idiopathic pulmonary fibrosis. Its Phase I/IIa clinical trial products consist of BIIB080 for patients with mild AD. The company's Phase I clinical trial products comprise Aducanumab for Alzheimer's disease; BIIB076, an anti-tau monoclonal antibody; and BIIB054 for Parkinson's disease. Biogen Inc. offers products through its sales force and marketing groups. The company was formerly known as Biogen Idec Inc. and changed its name to Biogen Inc. in March 2015. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration

Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat

Download on the App Store Get it on Google Play None Explore platform Show QR
Articles
Bitcoin is mid-cycle bull: analyst
Read more
SEC proposes FTX insider settlements, South Korean crypto counterfeit ring busted, Poland revives crypto bill | Weekly Recap
Read more
Midnight token hits record high as exchange listings ignite trading frenzy
Read more
Bitcoin options expire as bulls eye upside with $23B looming Dec. 26
Read more
1 BTC
Invest
50 BTC
Profit
Leverage:
x50

The Power Of Leverage

Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

BIIB price history

  • Last 7 days
  • Last 30 days
  • Last Year
  • Last 2 Years
  • Maximum Period
  • Daily
  • Weekly
  • Monthly
Date Close Change Chg% Open Min. Max.
2022-09-30 176.07 2.27 1.31 173.8 172.69 177.05
2022-09-30 174.73 2.07 1.20 172.66 172.66 175.3
2022-09-30 174.64 1.83 1.06 172.81 172.81 177.08
2022-09-30 173.55 2.96 1.74 170.59 170.09 176.14
2022-09-30 169.78 -0.68 -0.40 170.46 168.42 172.67
2022-09-30 171.86 2.42 1.43 169.44 168.64 173.54
2022-09-30 171.23 -1.35 -0.78 172.58 169.4 174.08
2022-09-30 175.54 2.97 1.72 172.57 169.9 175.78
2022-09-30 173.42 0.03 0.02 173.39 170.9 174.92
2022-09-30 172.52 -4.60 -2.60 177.12 171.9 180.57
2022-09-30 176.84 5.23 3.05 171.61 168.99 177.95
2022-09-30 175.69 -2.84 -1.59 178.53 174.69 181.07
2022-09-30 180.2 -0.01 -0.01 180.21 178.94 181.94
Go help.dzengi.com
Dzengi.com Exchange
Trade BTC & tokenized stocks